Kimon Tzannis
About
Kimon Tzannis is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology.
According to data from OpenAlex, Kimon Tzannis has authored 40 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Kimon Tzannis's work include Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (10 papers) and Renal cell carcinoma treatment (7 papers). Kimon Tzannis is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (10 papers) and Renal cell carcinoma treatment (7 papers). Kimon Tzannis collaborates with scholars based in Greece, United States and France. Kimon Tzannis's co-authors include Meletios Α. Dimopoulos, Aristotle Bamias, Flora Zagouri, Konstantinos Stravodimos, Bernard Escudier, Michalis Liontos, Athanasios Papatsoris, Aristotelis Bamias, Nikolaos Thomakos and Dimitrios Haidopoulos and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.
In The Last Decade
Kimon Tzannis
37 papers receiving 465 citations
Peers
Kimon Tzannis
Roohi Rasool India
Takafumi Minami Japan
Anja Bauerfeind Germany
Dzung Le United States
Haruhiko Yanagisawa Japan
Francesca Fioretti Italy
Jingru Tian China
N.Y. Haboubi United Kingdom
S. Petrasch Germany
Filiz Karagöz Türkiye
Citations per year, relative to Kimon Tzannis Kimon Tzannis (= 1×)
peers
Roohi Rasool
Countries citing papers authored by Kimon Tzannis
Since
Specialization
Citations
This map shows the geographic impact of Kimon Tzannis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimon Tzannis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimon Tzannis more than expected).
Fields of papers citing papers by Kimon Tzannis
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kimon Tzannis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimon Tzannis. The network helps show where Kimon Tzannis may publish in the future.
Co-authorship network of co-authors of Kimon Tzannis
This figure shows the co-authorship network connecting the top 25 collaborators of Kimon Tzannis. A scholar is included among the top collaborators of Kimon Tzannis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimon Tzannis. Kimon Tzannis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bamias, Aristotelis, et al.. (2024). Intravesical administration of Durvalumab to patients with high risk non muscle invasive bladder cancer who experience BCG failure. Final results from a phase II study by the Hellenic GU Cancer Group. European Urology. 85. S1716–S1716.
2.
Koutsoukos, Konstantinos, Roubini Zakopoulou, Kimon Tzannis, et al.. (2024). 1961O Nivolumab plus chemoradiotherapy in patients with non-metastatic muscle-invasive bladder cancer (nmMIBC), not undergoing cystectomy: A phase II, randomized study by the Hellenic GU Cancer Group. Annals of Oncology. 35. S1133–S1134.
3.
Syrigos, Nikolaos, Anna Zygogianni, Ioannis Georgakopoulos, et al.. (2024). Comprehensive 3DCRT Hypofractionated Radiotherapy Schedule for Localized Prostate Adenocarcinoma in the Era of IMRT: Dosimetric and Endoscopic Analysis. Cancers. 16(6). 1192–1192.
4.
Fiste, Oraianthi, Kimon Tzannis, Konstantinos Koutsoukos, et al.. (2023). 77P The impact of COVID-19 on gynecological cancer diagnoses in Greece. ESMO Open. 8(1). 100807–100807.
5.
Koukaki, Evangelia, Νikoletta Ρovina, Kimon Tzannis, et al.. (2022). Fungal Infections in the ICU during the COVID-19 Era: Descriptive and Comparative Analysis of 178 Patients. Journal of Fungi. 8(8). 881–881.
6.
Zoi, Vasiliki, Kimon Tzannis, Dimitra Kavatha, et al.. (2022). Clinical presentation and outcomes of chronic dialysis patients with COVID-19: A single center experience from Greece. World Journal of Nephrology. 11(2). 58–72.
7.
Bamias, Aristotelis, Axel S. Merseburger, Yohann Loriot, et al.. (2021). SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapy. ESMO Open. 6(3). 100152–100152.
8.
Papatsoris, Athanasios, Kimon Tzannis, N. Gavalas, et al.. (2020). A run-in phase clinical study for intravesical administration of durvalumab in patients with high-risk, non-muscle-invasive bladder cancer (NMIBC). European Urology Open Science. 19. e1177–e1178.
9.
Bagratuni, Tina, N. Gavalas, Kimon Tzannis, et al.. (2020). JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer. European Journal of Cancer. 126. 125–135.
10.
Bamias, Aristotelis, Axel Hegele, Jacques Médioni, et al.. (2019). Vinflunine in the treatment of relapsed metastatic urothelial cancer: A systematic review and meta-analysis of real-world series. Critical Reviews in Oncology/Hematology. 140. 80–87.
11.
Bamias, Aristotelis, Kimon Tzannis, Lauren C. Harshman, et al.. (2017). Impact of cisplatin-based therapy on long-term survival in advanced urinary tract cancer (aUTC). A retrospective international study of invasive/advanced cancer of the urothelium (RISC). Annals of Oncology. 28. v305–v305.
12.
Bamias, Aristotelis, Kimon Tzannis, Michalis Liontos, et al.. (2016). Patterns of chemotherapy utilization in metastatic urothelial cancer (mUC): analysis from the retrospective international study of invasive/advanced cancer of the urothelium (RISC) database. Annals of Oncology. 27. vi278–vi278.
13.
Pilalis, Eleftherios, Nikos G. Gavalas, Kimon Tzannis, et al.. (2016). The Development of an Angiogenic Protein “Signature” in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling. PLoS ONE. 11(6). e0156403–e0156403.
14.
Bamias, Aristotelis, Kimon Tzannis, Michalis Liontos, et al.. (2016). Adherence to cisplatin-based regimens prescription in "fit" patients fulfilling platinum eligibility criteria. Impact on outcomes: a retrospective international study of invasive/advanced cancer of the urothelium (RISC) analysis. Annals of Oncology. 27. vi278–vi278.
15.
Bamias, Aristotle, Stavros D. Peroukidis, Kimon Tzannis, et al.. (2015). Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG). Clinical Genitourinary Cancer. 14(2). e153–e159.
16.
Koutsoukos, Konstantinos, Kimon Tzannis, Christos Christodoulou, et al.. (2015). Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG). World Journal of Urology. 34(6). 853–857.
17.
Bamias, Aristotle, Kimon Tzannis, Athanasios Papatsoris, et al.. (2014). Prognostic Significance of Cytoreductive Nephrectomy in Patients With Synchronous Metastases From Renal Cell Carcinoma Treated With First-Line Sunitinib: A European Multiinstitutional Study. Clinical Genitourinary Cancer. 12(5). 373–383.
18.
Bamias, Aristotelis, Kimon Tzannis, Benoit Beuselinck, et al.. (2013). Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration. British Journal of Cancer. 109(2). 332–341.
19.
Dessinioti, Clio, Kimon Tzannis, Vana Sypsa, et al.. (2011). Epidemiologic risk factors of basal cell carcinoma development and age at onset in a Southern European population from Greece. Experimental Dermatology. 20(8). 622–626.
20.
Kummeling, Ischa, E. N. Clare Mills, Michael Clausen, et al.. (2009). The EuroPrevall surveys on the prevalence of food allergies in children and adults: background and study methodology. Allergy. 64(10). 1493–1497.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Roohi Rasool Breakdown of academic impact, for papers by Takafumi Minami Breakdown of academic impact, for papers by Anja Bauerfeind Breakdown of academic impact, for papers by Dzung Le Breakdown of academic impact, for papers by Haruhiko Yanagisawa Breakdown of academic impact, for papers by Francesca Fioretti Breakdown of academic impact, for papers by Jingru Tian Breakdown of academic impact, for papers by N.Y. Haboubi Breakdown of academic impact, for papers by S. Petrasch Breakdown of academic impact, for papers by Filiz Karagöz